Clinical trials recruiting in Trujillo, Peru
7
Recruiting trials
13
Conditions
Phase breakdown
Phase 2 1Phase 3 7
Conditions recruiting in Trujillo, Peru
Recruiting trials in Trujillo, Peru
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Common questions
How many clinical trials are recruiting in Trujillo, Peru?
7 recruiting trials have at least one study site in Trujillo, Peru.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.